E 3040

Bamba T, Matsui T, Mitsuyama K, et al. Clinical trial of a benzothiazole derivative (E3040), a dual inhibitor of 5-lipoxygenase and thromboxane synthetase, in the patients with active ulcerative colitis. Gut 1997 Oct; 41 Suppl. 3: A70 Oketani K, Murakami M, Inoue T, et al. Effect of E3040, a novel dual inhibitor of 5-lipoxygenase and thromboxane A2 synthetase, on experimental colitis. Jap J Pharmacol 1994; 64 Suppl. 1: 278